Hms Holdings Corp (HMSY) received a Buy rating and a $36 price target from Cantor Fitzgerald analyst Steven Halper today. The company’s shares opened today at $28.70.
Halper commented:
“. We are upgrading HMSY shares to and raising our 12-month price target to $36 from $34. The company has been posting solid top-line growth and margin expansion, which we believe should continue. After only 5.2% top-line growth in 2017, HMSY executed well in 2018 (about +15% y/y). In our view, future revenue growth will be driven by the company’s Total Population Management (TPM) solution. Payment Integrity (PI) revenue should also continue to be strong (+30% y/y in 2018). With this in mind and considering initiatives for future growth, we believe HMSY should be able to achieve higher top-line growth over the next several years. With 23% upside to our price target, our rating is Overweight.”
According to TipRanks.com, Halper is a 5-star analyst with an average return of 16.7% and a 60.0% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Evolent Health.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Hms Holdings Corp with a $37.50 average price target.
See today’s analyst top recommended stocks >>
Based on Hms Holdings Corp’s latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of $33.39 million. In comparison, last year the company had a net profit of $6.39 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HMS Holdings Corp. engages in the provision of cost containment solutions in the healthcare marketplace. It uses healthcare data technology, analytics, and related services to deliver coordination of benefits, payment, population risk intelligence, care management, and consumer engagement solutions to help payers reduce costs, and improve healthcare outcomes.
